Log In
BCIQ
Print this Print this
 

ICON-1 (formerly hI-con1)

  Manage Alerts
Collapse Summary General Information
Company Iconic Therapeutics Inc.
DescriptionAll-human chimeric, IgG-like homodimeric protein composed of a targeting domain (mutated, inactive factor VIIa) fused to an effector domain (Fc portion of IgG)
Molecular Target Factor VIIa
Mechanism of ActionFactor VIIa inhibitor
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today